Last checked at 10 Aug 2022 07:00
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
Belluscura PLC
("Belluscura" or the "Company" or "Group")
Exercise of Share Options and Total Voting Rights
Director / PDMR Shareholding and Share Options
LONDON, U.K. AND PLANO, TX, U.S. (10 August 2022). Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has received notification that Robert Rauker (CEO) has exercised options over 690,395 ordinary shares of 1 pence each ("Ordinary Shares") at an average exercise price of 11.7 pence, representing approximately 0.57% of the issued share capital. The consideration for the exercise of these Share Options amounts, in aggregate, to a cash value of £80,637.47. It is anticipated that shortly following Admission, 455,064 of these Shares will be beneficially transferred to Mr Rauker's ex-wife pursuant to a divorce settlement.
Immediately following Admission, and the aforementioned transfer, Mr Rauker's holding will be 1,646,079 shares and his total interest in the Company will be 1.34% of the Company's enlarged issued share capital.
The Company has also received notification from other option holders to exercise options over, in aggregate, 532,498 shares in the share capital of Belluscura at an exercise price of 6.5 pence. The consideration for the exercise of these share options amounts, in aggregate, to a cash value of £34,612.37.
The Company has today allotted 1,222,893 shares ("Option Shares") following the exercise of the above options.
Application has been made for the Option Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to be on or around 15 August 2022. These shares will rank pari passu with the ordinary shares of the Company in issue.
Total voting rights
The Company's total issued capital, after the issue of the New Ordinary Shares, will be 123,017,161 Ordinary Shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.
| |||||||||||||||||||||||||
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Robert Rauker | ||||
2 | Reason for notification | |||||
a) | Position / status | Chief Executive Officer | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Belluscura plc | ||||
b) | LEI | 213800BRJQZE56XBPW94 | ||||
4 | Details of the transaction(s): Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of £0.01 each in Belluscura plc ISIN : GB00BD3B8Z11 | ||||
b) | Nature of the transaction | (i) Exercise of options over ordinary shares; | ||||
c) | Price(s) and volumes(s) | (i)
| ||||
d) | Aggregated information | n/a | ||||
e) | Date of the transaction | 9 August 2022 | ||||
f) | Place of the transaction | Outside a trading venue | ||||